Urinary neutrophil gelatinase-associated lipocalin is a promising biomarker for late onset culture-positive sepsis in very low birth weight infants.
Urinary neutrophil gelatinase-associated lipocalin is a promising biomarker for late onset culture-positive sepsis in very low birth weight infants.
复制标题
DOI:
10.1203/pdr.0b013e3181da75c1
复制
发表时间:
2010-06
影响因子:
3.6
通讯作者:
Barasch JM
中科院分区:
文献类型:
--
作者:
Parravicini E;Nemerofsky SL;Michelson KA;Huynh TK;Sise ME;Bateman DA;Lorenz JM;Barasch JM
Need for the early identification of sepsis in very low birth weight (VLBW) infants has led to the search for reliable biomarkers. This study aims to determine whether urinary neutrophil gelatinase-associated lipocalin (uNGAL) rises in culture-positive sepsis and, if so, is elevated at the time sepsis is suspected. This is a prospective study of 91 VLBW infants whose urine was collected daily for uNGAL analysis. In 65 episodes of suspected sepsis, four groups were identified: A) culture-positive sepsis; B) single culture positive for S. epidermidis; C) and D) negative culture with antibiotic treatment for ≥ 7 days and < 7 days, respectively. Daily means of uNGAL of each group were estimated for comparison. Mean uNGAL in group A (179 ng/ml) was significantly elevated on the day blood culture was drawn (day 0) compared to the mean of healthy VLBW infants (6.5 ng/ml), and to the means in groups B, C and D (p<0.05). In group A mean uNGAL was significantly elevated on day 0 and daily for five days when compared with that of the day prior to culture (p <0.05 to < 0.005). uNGAL shows promise as an early marker for culture-positive sepsis in VLBW infants.